2nd Quarter - Termination
MGI PHARMA, INC. for MGI PHARMA INC
Firm
Client
Income
—
Expenses
$220,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Jul 1, 2008
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare and Medicaid Policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FEENEY | — |
| RAYMOND FROST | — |
| JENNIFER GRUBER | — |
Medical/Disease Research/Clinical Labs MED
Alzheimer's Disease Legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FEENEY | — |
| RAYMOND FROST | — |
Health Issues HCR
Health Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FEENEY | — |
| RAYMOND FROST | — |
| JENNIFER GRUBER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.